secwatch / observer
8-K filed March 1, 2022, 6:59 PM ET ticker TLPH CIK 0001427925
leadership confidence high sentiment neutral materiality 0.30

Director Mark G. Edwards to resign from AcelRx board effective March 31, 2022

TALPHERA, INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Mark G. Edwards

Director
TLPH · TALPHERA, INC.
Effective
2022-03-31
Filed
March 1, 2022, 6:59 PM ET
On February 23, 2022, Mark G. Edwards advised the board of directors of AcelRx Pharmaceuticals, Inc. of his intention to resign as a member of the board of directors effective March 31, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mark G. Edwards resigned as Director at TALPHERA, INC..

Action
resigned
Role
Director
Exact text from the filing
On February 23, 2022, Mark G. Edwards advised the board of directors of AcelRx Pharmaceuticals, Inc. of his intention to resign as a member of the board of directors effective March 31, 2022.
View on SEC.gov

TALPHERA, INC. filing history →

Source: SEC EDGAR
accession 0001437749-22-004844
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.